OneSource Specialty Pharma reports consolidated net profit of Rs 10.49 crore in the September 2025 quarter
Sales rise 12.49% to Rs 375.76 crore
Net profit of OneSource Specialty Pharma reported to Rs 10.49 crore in the quarter ended September 2025 as against net loss of Rs 42.08 crore during the previous quarter ended September 2024. Sales rose 12.49% to Rs 375.76 crore in the quarter ended September 2025 as against Rs 334.05 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var.Sales375.76334.05 12 OPM %28.3423.14 -PBDT75.5736.65 106 PBT5.74-31.63 LP NP10.49-42.08 LPPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content